Biocorrx Company Profile (OTCMKTS:BICX)

About Biocorrx (OTCMKTS:BICX)

Biocorrx logoBioCorRx, Inc., formerly Fresh Start Private Management, Inc., is a holding company. The Company is an addiction healthcare solutions company operating in Santa Ana, California. The Company, through its subsidiary, Fresh Start Private, Inc., provides alcoholism and opioid treatment program. It offers a medication-assisted treatment program that combines non-addictive medication coupled with psycho-social counseling. It also distributes and licenses the BioCorRx Recovery Program for alcoholism and opioid addiction treatment. The BioCorRxO Recovery Program consists of over two parts, which include an implant, administered by a licensed physician, of a compounded formulation of the drug, Naltrexone (implanted under the skin) (the Implant), which reduces alcohol cravings over a period of time, and a structured, intensive one on one counseling program developed by it. It offers BioCorRx Recovery Program in over 10 locations, including California, Arizona, Atlanta, Illinois and others.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:BICX
  • CUSIP: N/A
  • Web: www.biocorrx.com
Capitalization:
  • Market Cap: $22.77 million
  • Outstanding Shares: 239,711,000
Average Prices:
  • 50 Day Moving Avg: $0.11
  • 200 Day Moving Avg: $0.12
  • 52 Week Range: $0.01 - $0.34
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: $605,585.00
  • Price / Sales: 37.60
  • Book Value: ($0.18) per share
  • Price / Book: -0.52
Profitability:
  • EBIDTA: ($2,220,000.00)
Debt:
  • Debt-to-Equity Ratio: -0.02%
  • Current Ratio: 1.15%
  • Quick Ratio: 1.15%
Misc:
  • Average Volume: 660,229 shs.
  • Beta: 0.31
 
Frequently Asked Questions for Biocorrx (OTCMKTS:BICX)

What is Biocorrx's stock symbol?

Biocorrx trades on the OTCMKTS under the ticker symbol "BICX."

How were Biocorrx's earnings last quarter?

Biocorrx Inc. (OTCMKTS:BICX) issued its quarterly earnings results on Thursday, November, 17th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm earned $0.17 million during the quarter. View Biocorrx's Earnings History.

Who are some of Biocorrx's key competitors?

Who are Biocorrx's key executives?

Biocorrx's management team includes the folowing people:

  • Brady J. Granier, President, Chief Executive Officer, Director
  • Lourdes Felix, Chief Financial Officer, Chief Operating Officer, Treasurer, Director
  • Tom Welch, Director - Operations
  • Kent Emry, Director

How do I buy Biocorrx stock?

Shares of Biocorrx can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Biocorrx's stock price today?

One share of Biocorrx stock can currently be purchased for approximately $0.10.


MarketBeat Community Rating for Biocorrx (OTCMKTS BICX)
Community Ranking:  2.5 out of 5 (  )
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  6
MarketBeat's community ratings are surveys of what our community members think about Biocorrx and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Biocorrx (OTCMKTS:BICX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Biocorrx (OTCMKTS:BICX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Biocorrx (OTCMKTS:BICX)
Earnings by Quarter for Biocorrx (OTCMKTS:BICX)
Earnings History by Quarter for Biocorrx (OTCMKTS BICX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/17/2016Q3 2016($0.02)$0.17 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Biocorrx (OTCMKTS:BICX)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Biocorrx (OTCMKTS:BICX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Biocorrx (OTCMKTS:BICX)
Insider Ownership Percentage: 14.85%
Insider Trades by Quarter for Biocorrx (OTCMKTS:BICX)
Insider Trades by Quarter for Biocorrx (OTCMKTS:BICX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/27/2015Jorge Andrade JrDirectorSell125,000$0.06$7,500.00View SEC Filing  
2/26/2015Jorge Andrade JrDirectorSell245,000$0.05$12,250.00View SEC Filing  
2/23/2015Jorge Andrade JrDirectorSell215,000$0.06$12,900.00View SEC Filing  
2/17/2015Jorge Andrade JrDirectorSell90,000$0.08$7,200.00View SEC Filing  
2/10/2015Jorge Andrade JrDirectorSell60,000$0.09$5,400.00View SEC Filing  
10/28/2014Jorge Andrade JrDirectorSell25,000$0.09$2,250.00View SEC Filing  
10/13/2014Jorge Andrade JrDirectorSell80,000$0.09$7,200.00View SEC Filing  
10/7/2014Jorge Andrade JrDirectorSell40,000$0.11$4,400.00View SEC Filing  
10/1/2014Jorge Andrade JrDirectorSell30,000$0.13$3,900.00View SEC Filing  
9/29/2014Jorge Andrade JrDirectorSell170,000$0.10$17,000.00View SEC Filing  
9/22/2014Jorge Andrade JrDirectorSell130,000$0.10$13,000.00View SEC Filing  
9/15/2014Jorge Andrade JrDirectorSell90,000$0.10$9,000.00View SEC Filing  
9/8/2014Jorge Andrade JrDirectorSell95,000$0.11$10,450.00View SEC Filing  
8/22/2014Jorge Andrade JrDirectorSell100,000$0.13$13,000.00View SEC Filing  
8/14/2014Jorge Andrade JrDirectorSell300,000$0.14$42,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Biocorrx (OTCMKTS:BICX)
Latest Headlines for Biocorrx (OTCMKTS:BICX)
Source:
DateHeadline
finance.yahoo.com logoBioCorRx Announces First Addiction Treatment Center in South Florida to Implement the BioCorRx Program
finance.yahoo.com - July 21 at 6:11 PM
finance.yahoo.com logoBioCorRx to Exhibit at ASAM Conference in Dallas, Texas
finance.yahoo.com - July 6 at 4:07 PM
finance.yahoo.com logoBioCorRx CEO Brady Granier Appears on Fox 11 Morning News Los Angeles; Anaheim Residents Encouraged to Seek Treatment
finance.yahoo.com - June 8 at 4:41 PM
finanznachrichten.de logoBioCorRx Inc.: BioCorRx to Present at the 2017 Marcum Microcap Conference
www.finanznachrichten.de - June 7 at 4:13 PM
finance.yahoo.com logoBioCorRx to Present at the 2017 Marcum Microcap Conference
finance.yahoo.com - June 7 at 9:49 AM
finance.yahoo.com logoBioCorRx Partners with the Virtual Reality Medical Center and Physicians at Scripps Memorial Hospital for Naltrexone Implant Study, Grant Assistance and Strategic Partnerships​
finance.yahoo.com - June 1 at 4:21 PM
finance.yahoo.com logoBioCorRx to Host Grand Opening Ribbon Cutting, Support Drug Free Anaheim Initiative in the City of Anaheim
finance.yahoo.com - May 30 at 12:23 PM
finance.yahoo.com logoBioCorRx Granted Pre-IND Meeting with FDA for BICX101
finance.yahoo.com - May 25 at 5:01 PM
finance.yahoo.com logoBioCorRx Submits Listing Application for the NASDAQ Capital Market
finance.yahoo.com - May 16 at 12:38 PM
finance.yahoo.com logoBioCorRx Provides Business Update for the First Quarter of 2017
finance.yahoo.com - May 15 at 9:04 AM
finance.yahoo.com logoBioCorRx CEO Brady Granier Appears on Fox & Friends
finance.yahoo.com - May 3 at 6:38 PM
finance.yahoo.com logoBioCorRx Collaborating with DynamiCare Health to Develop Mobile Application for Patients with Opioid and Alcohol Addiction
finance.yahoo.com - April 24 at 10:09 AM
finance.yahoo.com logoBioCorRx Submits Meeting Request for Pre-IND Meeting with FDA for BICX101
finance.yahoo.com - April 10 at 11:43 AM
finance.yahoo.com logoBioCorRx Announces BICX101 Preclinical Update; ASAM Attendance
finance.yahoo.com - April 7 at 8:30 AM
finance.yahoo.com logoPrivate Equity Firm Alpine Creek Completes Equity Financing of Biotech BioCorRx
finance.yahoo.com - April 2 at 3:47 PM
finance.yahoo.com logoBioCorRx CEO Brady Granier Appears on Fox Business Network
finance.yahoo.com - March 28 at 1:08 PM
finance.yahoo.com logoBrady Granier, CEO, President, and Director and Lourdes Felix, CFO, COO and Director of BioCorRx Inc. Provide Updates and Outlook in a New Audio Interview with SmallCapVoice.com
finance.yahoo.com - March 27 at 11:10 AM
finance.yahoo.com logoBioCorRx Announces Upgrade to the OTCQB(R)
finance.yahoo.com - March 22 at 3:35 PM
finance.yahoo.com logoBioCorRx Announces Updates on Preclinical Studies of BICX101 and Pre-IND Meeting Request with FDA
finance.yahoo.com - March 21 at 4:15 PM
finance.yahoo.com logoBioCorRx to Present at the Sidoti & Company Spring 2017 Convention in NYC
finance.yahoo.com - March 15 at 4:13 PM
finance.yahoo.com logoBioCorRx Completes $940,000 Equity Financing and Announces Alpine Creek Capital has Agreed to Invest an Additional $1.7 Million
finance.yahoo.com - March 10 at 4:45 PM
finance.yahoo.com logoAmerica's War on Drugs
finance.yahoo.com - March 7 at 12:35 PM
finance.yahoo.com logoWho Is Winning the Fight Against Opioid Abuse?
finance.yahoo.com - February 27 at 3:20 PM
finance.yahoo.com logoBioCorRx Provides Preclinical Study Update on BICX101 Development
finance.yahoo.com - February 23 at 3:21 PM
finance.yahoo.com logoDrug Addiction Treatment Stocks to Watch
finance.yahoo.com - February 22 at 3:56 PM
finance.yahoo.com logoBioCorRx Announces the Appointment of Dr. Balbir S. Brar as VP of Drug Development
finance.yahoo.com - February 21 at 10:41 AM
finance.yahoo.com logoANGEL Program Gets National Attention
finance.yahoo.com - February 13 at 4:25 PM
finance.yahoo.com logoBioCorRx Provides Business Update Webcast
finance.yahoo.com - February 10 at 3:23 PM
biz.yahoo.com logoBIOCORRX INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - February 8 at 4:04 PM
finance.yahoo.com logoBioCorRx to Collaborate with the City of Anaheim to Treat Opioid and Alcohol Addiction
finance.yahoo.com - February 8 at 4:04 PM
seekingalpha.com logo21st Century Cures Act Hopes To Reduce $41 Billion Annual Cost Of Opioid Treatments
seekingalpha.com - January 22 at 3:53 PM
finance.yahoo.com logoJGR Capital Partners Initiates Coverage on BioCorRx Inc. with a Price Target of $0.09
finance.yahoo.com - January 19 at 8:24 PM
finance.yahoo.com logoBioCorRx Retains Innovative Science Solutions to Guide FDA Regulatory Process for its Naltrexone Products
finance.yahoo.com - January 12 at 4:09 PM
finance.yahoo.com logoBioCorRx Inc. to Present at the 9th Annual LD Micro Main Event
finance.yahoo.com - December 2 at 10:13 AM
finance.yahoo.com logoBioCorRx Selects Covance for Non-Clinical Studies, Announces the Addition of Dr. Bal S. Brar to its Drug Development Team, Plans Pre-IND Meeting with FDA
finance.yahoo.com - November 29 at 2:57 PM
finance.yahoo.com logoBioCorRx Inc. to Host Corporate Update Webinar on Wednesday, October 12th at 2:00 p.m. Eastern Time
finance.yahoo.com - October 6 at 9:21 AM
finance.yahoo.com logoBioCorRx Inc. Announces Update From First Joint Steering Committee Meeting for Injectable Naltrexone Product
finance.yahoo.com - September 15 at 12:44 PM
finance.yahoo.com logoBioCorRx Inc. Announces BioCorRx Pharmaceuticals Subsidiary; Forms Joint Steering Committee for Injectable Naltrexone Technology
finance.yahoo.com - August 31 at 3:49 PM
finance.yahoo.com logoBioCorRx, Inc. Announces Agreement With Dr. David Gastfriend to Provide Strategic Initiative and Corporate Development Consulting
finance.yahoo.com - August 17 at 12:00 PM
biz.yahoo.com logoBIOCORRX INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - August 3 at 12:30 PM
finance.yahoo.com logoBioCorRx Retains MZ Group as Investor Relations Advisor
finance.yahoo.com - July 20 at 10:28 AM
finance.yahoo.com logoBioCorRx Launches R&D Initiative to Pursue FDA Approval for Naltrexone Implant
finance.yahoo.com - July 14 at 8:00 AM
finance.yahoo.com logoAlpine Creek and BioCorRx Announce Major Investment Into BioCorRx
finance.yahoo.com - June 20 at 2:01 PM
biz.yahoo.com logoBIOCORRX INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statemen
biz.yahoo.com - May 20 at 5:05 PM
biz.yahoo.com logoBIOCORRX INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Statements and Exhibits
biz.yahoo.com - April 18 at 4:13 PM
biz.yahoo.com logoBIOCORRX INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - April 14 at 2:55 PM
finance.yahoo.com logoBioCorRx's Program to Help Beat Alcohol and Opioid Addiction Now in 20 Locations and Growing in Time for Alcohol Awareness Month
finance.yahoo.com - April 4 at 8:24 AM

Social

Chart

Biocorrx (BICX) Chart for Sunday, July, 23, 2017

This page was last updated on 7/23/2017 by MarketBeat.com Staff